Cancer Control Journal Vol 4, No 3
CME Pretest

In this issue, topics addressed include breast cancer, gastric lymphoma, and rheumatologic conditions associated with cancer. First, answer the pretest questions below. After reading the articles, proceed with answering the CME posttest questions.

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicians can earn up to 4 credit hours of Category I for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• be familiar with indications for and results of breast conservation therapy,
  
• recognize a role for selective lymphadenectomy in breast cancer,
  
• understand several controversies in breast cancer management,
• know the approaches to managing gastric lymphoma, and
• be familiar with associations between rheumatologic and neoplastic disease.

This program was planned in accordance with ACCME Essentials.
Release Date: May 1, 1997 Expiration Date: May 1, 1998

Pretest

1. The single most important determinant of cosmetic outcome following breast conservation therapy is:

a. total radiation dose

b. use of chemotherapy

c. large breast size

d. extent of surgery

2. What characteristic was most often associated with unsuccessful mapping of the sentinel lymph node?

a. large breast

b. inner-quadrant lesion

c. associated fibrocystic change

d. presence of ductal carcinoma in situ

3. The mucosa-associated lymphoid tissue (MALT) tumor is predominantly of which lymphoma type?

a. B-cell

b. null-cell

c. T-cell

d. mixed